Back to Search
PAUL RENNIE, DO
DO
Neuromusculoskeletal Medicine & OMM Physician
NPI: 1578717781IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine Physician
Family Medicine
Code: 207Q00000X
579(NV)
Neuromusculoskeletal Medicine & OMM PhysicianPrimary
Neuromusculoskeletal Medicine & OMM
Code: 204D00000X
579(NV)
Education
OTHER
Class of 1987
Research & Publications (20)
Castration induces autoantibody and T cell responses that correlate with inferior outcomes in an androgen-dependent murine tumor model.
PMID 19554630·Int J Cancer·2009
7-preclinical
In vivo knockdown of the androgen receptor results in growth inhibition and regression of well-established, castration-resistant prostate tumors.
PMID 19118031·Clin Cancer Res·2009
7-preclinical
p54nrb is a transcriptional corepressor of the progesterone receptor that modulates transcription of the labor-associated gene, connexin 43 (Gja1).
PMID 19423654·Mol Endocrinol·2009
7-preclinical
Lentiviruses with trastuzumab bound to their envelopes can target and kill prostate cancer cells.
PMID 19373278·Cancer Gene Ther·2009
7-preclinical
MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells.
PMID 19671871·Clin Cancer Res·2009
7-preclinical
Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer.
PMID 18559493·Cancer Res·2008
7-preclinical
[Oncolytic vesicular stomatitis viruses as intravesical agents against non-muscle-invasive bladder cancer].
PMID 18670747·Urologe A·2008
7-preclinical
Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT.
PMID 18316794·J Clin Oncol·2008
3-trial
DJ-1 binds androgen receptor directly and mediates its activity in hormonally treated prostate cancer cells.
PMID 17510388·Cancer Res·2007
8-other
Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells.
PMID 17553164·Mol Cancer·2007
4-observational
Effects of creating a non-specific, virus-hostile environment in the nasopharynx on symptoms and duration of common cold.
PMID 17608134·Acta Otorhinolaryngol Ital·2007
2-rct
Standard treatments induce antigen-specific immune responses in prostate cancer.
PMID 17332294·Clin Cancer Res·2007
7-preclinical
Low pH gel intranasal sprays inactivate influenza viruses in vitro and protect ferrets against influenza infection.
PMID 17509128·Respir Res·2007
7-preclinical
Inhibition of rhinovirus replication in vitro and in vivo by acid-buffered saline.
PMID 17357049·J Infect Dis·2007
3-trial
Increased expression and differential phosphorylation of stathmin may promote prostate cancer progression.
PMID 17455228·Prostate·2007
7-preclinical
An HSV-1 amplicon system for prostate-specific expression of ICP4 to complement oncolytic viral replication for in vitro and in vivo treatment of prostate cancer cells.
PMID 17479106·Cancer Gene Ther·2007
7-preclinical
Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines.
PMID 17337101·Clin Nutr·2007
8-other
Androgen receptor regulation of the versican gene through an androgen response element in the proximal promoter.
PMID 17728259·J Biol Chem·2007
8-other
Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity.
PMID 17974989·Cancer Res·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 874 AMERICAN PACIFIC DR
HENDERSON, NV 89014 - Phone
- (702) 777-4809
Quick Facts
- NPI
- 1578717781
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile